Anders Cervin

13.0k total citations
81 papers, 1.8k citations indexed

About

Anders Cervin is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Anders Cervin has authored 81 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Otorhinolaryngology, 29 papers in Pulmonary and Respiratory Medicine and 27 papers in Physiology. Recurrent topics in Anders Cervin's work include Sinusitis and nasal conditions (25 papers), Respiratory and Cough-Related Research (21 papers) and Asthma and respiratory diseases (21 papers). Anders Cervin is often cited by papers focused on Sinusitis and nasal conditions (25 papers), Respiratory and Cough-Related Research (21 papers) and Asthma and respiratory diseases (21 papers). Anders Cervin collaborates with scholars based in Sweden, Australia and United Kingdom. Anders Cervin's co-authors include Ben Wallwork, Staffan I. Lindberg, Lennart Greiff, Alan Mackay‐Sim, William B. Coman, Lars‐Olaf Cardell, Thomas Runer, Rolf Uddman, Morgan Andersson and Johan Hellgren and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Infectious Diseases and British Journal of Anaesthesia.

In The Last Decade

Anders Cervin

77 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Cervin Sweden 24 853 669 597 504 388 81 1.8k
Henrik Malmberg Finland 26 503 0.6× 963 1.4× 772 1.3× 543 1.1× 423 1.1× 59 1.9k
Edwin Tamashiro Brazil 23 558 0.7× 313 0.5× 199 0.3× 325 0.6× 415 1.1× 68 1.6k
W. J. Fokkens Netherlands 20 408 0.5× 746 1.1× 740 1.2× 438 0.9× 377 1.0× 41 1.5k
Péter Clement Belgium 29 1.3k 1.5× 1.2k 1.8× 1.1k 1.8× 1.2k 2.4× 582 1.5× 120 2.9k
Do‐Yeon Cho United States 24 736 0.9× 272 0.4× 169 0.3× 718 1.4× 529 1.4× 99 1.9k
Adrian Drake‐Lee United Kingdom 19 517 0.6× 409 0.6× 399 0.7× 408 0.8× 321 0.8× 79 1.3k
Chaweewan Bunnag Thailand 17 339 0.4× 515 0.8× 774 1.3× 212 0.4× 126 0.3× 79 1.2k
Jean‐Silvain Lacroix Switzerland 16 236 0.3× 285 0.4× 154 0.3× 217 0.4× 198 0.5× 30 1.3k
Fuad M. Baroody United States 39 1.3k 1.5× 2.7k 4.0× 2.5k 4.2× 1.0k 2.1× 1.1k 2.8× 179 4.6k
Andrew Thamboo Canada 22 696 0.8× 225 0.3× 278 0.5× 715 1.4× 233 0.6× 96 1.4k

Countries citing papers authored by Anders Cervin

Since Specialization
Citations

This map shows the geographic impact of Anders Cervin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Cervin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Cervin more than expected).

Fields of papers citing papers by Anders Cervin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Cervin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Cervin. The network helps show where Anders Cervin may publish in the future.

Co-authorship network of co-authors of Anders Cervin

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Cervin. A scholar is included among the top collaborators of Anders Cervin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Cervin. Anders Cervin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yarlagadda, Tejasri, et al.. (2025). Lactobacillus rhamnosus D3189 modulates antiviral and inflammatory responses in primary nasal epithelial cells, reducing respiratory syncytial virus shedding. Frontiers in Cellular and Infection Microbiology. 15. 1625517–1625517.
2.
Yarlagadda, Tejasri, et al.. (2024). Lactobacillus rhamnosus dampens cytokine and chemokine secretion from primary human nasal epithelial cells infected with rhinovirus. Journal of Applied Microbiology. 135(2). 5 indexed citations
3.
Toppila‐Salmi, Sanna, Leif Bjermer, Lars‐Olaf Cardell, et al.. (2024). Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights. Journal of Asthma and Allergy. Volume 17. 431–439. 3 indexed citations
4.
Mårtensson, Anders, et al.. (2022). Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo‐controlled crossover trial. Clinical & Experimental Allergy. 52(6). 774–783. 11 indexed citations
5.
Heal, Clare, et al.. (2019). Oral corticosteroids for painful acute otitis externa (swimmer’s ear): A triple-blind randomised controlled trial. Australian Journal of General Practice. 48(8). 565–572. 2 indexed citations
6.
Cervin, Anders, et al.. (2018). Long-term patient-related outcome measures of septoplasty: a systematic review. European Archives of Oto-Rhino-Laryngology. 275(5). 1039–1048. 33 indexed citations
7.
Kahlon, Babar, C. Svensson, Anders Cervin, et al.. (2017). Quality of Life and Work Capacity Are Unrelated to Approach or Complications After Pituitary Surgery. World Neurosurgery. 108. 24–32. 4 indexed citations
8.
Cervin, Anders, et al.. (2016). The impact of topical betamethasone nasal irrigation on endogenous cortisol production in patients following functional endoscopic sinus surgery for chronic rhinosinusitis. Allergy. 71. 14–14.
9.
Cervin, Anders, et al.. (2016). Melioidosis in a patient with chronic rhinosinusitis. The Journal of Laryngology & Otology. 130(S4). S60–S62. 7 indexed citations
10.
Vasani, Sarju, et al.. (2016). Rising incidence of head and neck mucosal melanoma in Australia. The Journal of Laryngology & Otology. 131(S2). S25–S28. 8 indexed citations
11.
Greiff, Lennart, Cecilia Ahlström‐Emanuelsson, Gun Almqvist, et al.. (2015). Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study. Inflammation Research. 64(11). 903–915. 21 indexed citations
13.
Cervin, Anders & Ben Wallwork. (2014). Efficacy and Safety of Long-Term Antibiotics (Macrolides) for the Treatment of Chronic Rhinosinusitis. Current Allergy and Asthma Reports. 14(3). 416–416. 35 indexed citations
14.
Greiff, Lennart, Anders Cervin, Cecilia Ahlström‐Emanuelsson, et al.. (2012). Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis. Respiratory Research. 13(1). 53–53. 44 indexed citations
15.
Cervin, Anders, et al.. (2011). Can we always trust rhinomanometry?. Rhinology Journal. 49(1). 46–52. 22 indexed citations
16.
Hellgren, Johan, et al.. (2009). Allergic rhinitis and the common cold – high cost to society. Allergy. 65(6). 776–783. 143 indexed citations
17.
Cardell, Lars‐Olaf, Mariette Andersson, Anders Cervin, et al.. (2009). Genes regulating molecular and cellular functions in noninfectious nonallergic rhinitis. Allergy. 64(9). 1301–1308. 4 indexed citations
18.
Cervin, Anders & Ben Wallwork. (2005). Anti-inflammatory Effects of Macrolide Antibiotics in the Treatment of Chronic Rhinosinusitis. Otolaryngologic Clinics of North America. 38(6). 1339–1350. 25 indexed citations
19.
Cervin, Anders, et al.. (1999). Functional Effects of Neuropeptide Y Receptors on Blood Flow and Nitric Oxide Levels in the Human Nose. American Journal of Respiratory and Critical Care Medicine. 160(5). 1724–1728. 23 indexed citations
20.
Janson, Håkan, Birgitta Carlén, Anders Cervin, et al.. (1999). Effects on the Ciliated Epithelium of Protein D–Producing and –Nonproducing NontypeableHaemophilus influenzaein Nasopharyngeal Tissue Cultures. The Journal of Infectious Diseases. 180(3). 737–746. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026